SOPHiA GENETICS SA

NasdaqGS:SOPH Stok Raporu

Piyasa değeri: US$241.7m

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

SOPHiA GENETICS Yönetim

Yönetim kriter kontrolleri 3/4

SOPHiA GENETICS' CEO is Jurgi Camblong, appointed in Mar 2011, has a tenure of 13.58 years. directly owns 3.72% of the company’s shares, worth $8.98M. The average tenure of the management team and the board of directors is 4.2 years and 4.3 years respectively.

Anahtar bilgiler

Jurgi Camblong

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesin/a
CEO görev süresi13.6yrs
CEO sahipliği3.7%
Yönetim ortalama görev süresi4.2yrs
Yönetim Kurulu ortalama görev süresi4.3yrs

Son yönetim güncellemeleri

Recent updates

SOPHiA GENETICS SA (NASDAQ:SOPH) Just Reported, And Analysts Assigned A US$6.00 Price Target

Aug 09
SOPHiA GENETICS SA (NASDAQ:SOPH) Just Reported, And Analysts Assigned A US$6.00 Price Target

Investors Still Waiting For A Pull Back In SOPHiA GENETICS SA (NASDAQ:SOPH)

Aug 08
Investors Still Waiting For A Pull Back In SOPHiA GENETICS SA (NASDAQ:SOPH)

SOPHiA GENETICS SA (NASDAQ:SOPH) Full-Year Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Mar 09
SOPHiA GENETICS SA (NASDAQ:SOPH) Full-Year Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Sophia Genetics: Breakthrough Potential In A Cautious Healthcare Sector

Feb 12

Here's Why We're Not Too Worried About SOPHiA GENETICS' (NASDAQ:SOPH) Cash Burn Situation

Dec 27
Here's Why We're Not Too Worried About SOPHiA GENETICS' (NASDAQ:SOPH) Cash Burn Situation

Why Investors Shouldn't Be Surprised By SOPHiA GENETICS SA's (NASDAQ:SOPH) 35% Share Price Surge

Nov 09
Why Investors Shouldn't Be Surprised By SOPHiA GENETICS SA's (NASDAQ:SOPH) 35% Share Price Surge

Is SOPHiA GENETICS (NASDAQ:SOPH) In A Good Position To Invest In Growth?

Aug 08
Is SOPHiA GENETICS (NASDAQ:SOPH) In A Good Position To Invest In Growth?

Here's Why We're Watching SOPHiA GENETICS' (NASDAQ:SOPH) Cash Burn Situation

Dec 15
Here's Why We're Watching SOPHiA GENETICS' (NASDAQ:SOPH) Cash Burn Situation

SOPHiA GENETICS partnering with Boundless Bio on oncogene cancer therapies

Sep 21

SOPHiA Genetics GAAP EPS of -$0.39 in-line, revenue of $11.7M misses by $0.25M

Aug 09

We're Hopeful That SOPHiA GENETICS (NASDAQ:SOPH) Will Use Its Cash Wisely

Jul 01
We're Hopeful That SOPHiA GENETICS (NASDAQ:SOPH) Will Use Its Cash Wisely

SOPHiA GENETICS SA (NASDAQ:SOPH) Just Reported Earnings, And Analysts Cut Their Target Price

Mar 18
SOPHiA GENETICS SA (NASDAQ:SOPH) Just Reported Earnings, And Analysts Cut Their Target Price

We Think SOPHiA GENETICS (NASDAQ:SOPH) Can Afford To Drive Business Growth

Mar 10
We Think SOPHiA GENETICS (NASDAQ:SOPH) Can Afford To Drive Business Growth

Here's Why We're Not Too Worried About SOPHiA GENETICS' (NASDAQ:SOPH) Cash Burn Situation

Nov 24
Here's Why We're Not Too Worried About SOPHiA GENETICS' (NASDAQ:SOPH) Cash Burn Situation

CEO Tazminat Analizi

Jurgi Camblong'un ücretlendirmesi SOPHiA GENETICS'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

-US$67m

Mar 31 2024n/an/a

-US$73m

Dec 31 2023n/an/a

-US$79m

Sep 30 2023n/an/a

-US$69m

Jun 30 2023n/an/a

-US$78m

Mar 31 2023n/an/a

-US$82m

Dec 31 2022US$3mUS$507k

-US$87m

Sep 30 2022n/an/a

-US$95m

Jun 30 2022n/an/a

-US$93m

Mar 31 2022n/an/a

-US$86m

Dec 31 2021US$8mUS$394k

-US$74m

Tazminat ve Piyasa: Insufficient data to establish whether Jurgi's total compensation is reasonable compared to companies of similar size in the US market.

Tazminat ve Kazançlar: Jurgi's compensation has been consistent with company performance over the past year.

CEO

Jurgi Camblong (46 yo)

13.6yrs

Görev süresi

US$3,332,361

Tazminat

Dr. Jurgi Camblong, Ph D., M.B.A., serves as Chief Executive Officer and Director of SOPHiA GENETICS SA since March 2011. Dr. Camblong Co-founded SOPHiA GENETICS SA since March 2011.In 2010, Dr. Camblong...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Jurgi Camblong
Co-Founder13.6yrsUS$3.33m3.72%
$ 9.0m
Ross Muken
Executive VP3.7yrsVeri yok0.093%
$ 224.6k
Abhimanyu Verma
Senior VP & CTO2.8yrsVeri yokVeri yok
Zhenyu Xu
Executive VP & Chief Scientific Officer3.8yrsVeri yok0.63%
$ 1.5m
Katherine Bailon
Vice President of Investor Relationsno dataVeri yokVeri yok
Daan van Well
Executive VP5.3yrsVeri yok0.14%
$ 335.2k
Manuela Da Valente
Executive VP & Chief People Officer5.8yrsVeri yok0.060%
$ 145.6k
Kevin Puylaert
VP & MD of EMEA1.2yrsVeri yokVeri yok
Philippe Menu
Executive VP4.7yrsVeri yok0.063%
$ 152.4k

4.2yrs

Ortalama Görev Süresi

44.5yo

Ortalama Yaş

Deneyimli Yönetim: SOPH's management team is considered experienced (4.2 years average tenure).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Jurgi Camblong
Co-Founder13.6yrsUS$3.33m3.72%
$ 9.0m
Kathy Hibbs
Independent Non-Executive Director3.8yrsUS$257.20k0.057%
$ 136.6k
Didier Hirsch
Independent Non-Executive Director4.3yrsUS$265.94k0.11%
$ 272.0k
Jean-Michel Yves Cossery
Independent Director2.8yrsUS$218.17k0.096%
$ 231.4k
Vincent Ossipow
Independent Non-Executive Director10.3yrsUS$233.53k0.60%
$ 1.4m
Tomer Berkovitz
Independent Non-Executive Director3.6yrsVeri yokVeri yok
Troy Cox
Independent Non-Executive Chairman5.3yrsUS$290.93k0.28%
$ 678.7k

4.3yrs

Ortalama Görev Süresi

60yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: SOPH's board of directors are considered experienced (4.3 years average tenure).